MAMohammed A. Al-Duais
Mohammed A. Al-Duais
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammed A. Al-Duais has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adel Ibrahim Alalawy
Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia
1 shared publication - Ahmed A. Tayel
Department of Fish Processing and Biotechnology, Faculty of Aquatic and Fisheries Sciences, Kafrelsheikh University, Kafrelsheikh, Egypt
1 shared publication - Fahad Mohamed Almutairi
Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publication - Haddad Abdulsameih El-Rabey
Biochemistry Department, Faculty of Science, University of Tabuk
1 shared publication - Mohamed I. Sakran
Biochemistry section, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt
1 shared publication - Nahla S. Zidan
Department of Nutrition and Food Science, Faculty of Home Economics, Tabuk University, Tabuk 47512, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 23 May 2020
- Published by Wiley in International Journal of Polymer Science
- Vol. 2020, 1-9
Effectual Anticancer Potentiality of Loaded Bee Venom onto Fungal Chitosan Nanoparticles
Chitosan and its nanoparticles (NPs) could be extracted from numerous fungal species and used as effectual carriers for bioactive compounds. The fungal chitosan (FC) was innovatively acquired from Fusarium oxysporum grown mycelia, characterized and used for NP synthesis and loading with bee venom (BV). The nano-FC (NFC) had 192.4 nm mean NP diameter, 38.22% loading capacity, and 92.42% entrapment efficiency. BV release from NFC was pH and time dependent; burst BV release was detected at the first 6 h, followed by gradual releases up to 30 h. The in vitro anticancer potentiality valuation, of NFC, BV, and NFC/BV nanoconjugates against HeLa cervix carcinoma, revealed that they all had potent dose-dependent anticancer activity; BV/NFC nanoconjugates were the most effective with . The fluorescent staining of treated HeLa cells with BV/NFC nanoconjugates, with DAPI and acridine orange/propidium iodide combination, indicated the appearance of early apoptosis, secondary apoptosis, and secondary necrosis markers and their increment with exposure prolongation. The production of NFC from F. oxysporum and their loading with BV are strongly counseled for production of potent natural antitumor agent with augmented activity against cervix carcinoma.- 23 May 2020
- Published by Wiley in International Journal of Polymer Science
- Vol. 2020, 1-9
Open AccessEffectual Anticancer Potentiality of Loaded Bee Venom onto Fungal Chitosan Nanoparticles
Chitosan and its nanoparticles (NPs) could be extracted from numerous fungal species and used as effectual carriers for bioactive compounds. The fungal chitosan (FC) was innovatively acquired from Fusarium oxysporum grown mycelia, characterized and used for NP synthesis and loading with bee venom (BV). The nano-FC (NFC) had 192.4 nm mean NP diameter, 38.22% loading capacity, and 92.42% entrapment efficiency. BV release from NFC was pH and time dependent; burst BV release was detected at the first 6 h, followed by gradual releases up to 30 h. The in vitro anticancer potentiality valuation, of NFC, BV, and NFC/BV nanoconjugates against HeLa cervix carcinoma, revealed that they all had potent dose-dependent anticancer activity; BV/NFC nanoconjugates were the most effective with . The fluorescent staining of treated HeLa cells with BV/NFC nanoconjugates, with DAPI and acridine orange/propidium iodide combination, indicated the appearance of early apoptosis, secondary apoptosis, and secondary necrosis markers and their increment with exposure prolongation. The production of NFC from F. oxysporum and their loading with BV are strongly counseled for production of potent natural antitumor agent with augmented activity against cervix carcinoma.